(ECT) |
| 0 (0%) 01-13 20:23 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 0.39 |
| Resistance 1: | 0.33 |
| Pivot price: | 0.30 |
| Support 1: | 0.27 |
| Support 2: | 0.23 |
| 52w High: | |
| 52w Low: |
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Tue, 13 Jan 2026
Investor-State Arbitration Laws and Regulations Report 2026 The Impact of EU Law on Intra-EU BITs, the ECT, Sports Arbitration and the MIC - ICLG.com
Tue, 13 Jan 2026
Biology may influence who benefits from ECT treatment - Universitetet i Bergen
Sun, 11 Jan 2026
The first psychiatrist to administer ECT in North America. - Psychology Today
Thu, 08 Jan 2026
President von der Leyen travels to the Middle East promoting cooperation, prosperity and stability in the region - European Commission
Mon, 24 Nov 2025
Electroconvulsive therapy (ECT): It’s Not Just the Memory Loss - Mad In America
Wed, 19 Nov 2025
Electroconvulsive therapy may have more adverse effects than thought - The Guardian
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |